Log In
Print this Print this

ADAMTS13 (BAX 930)

  Manage Alerts
Collapse Summary General Information
Company Shire plc
DescriptionRecombinant human ADAMTS13
Molecular Target ADAM metallopeptidase with thrombospondin type 1 motif 13 (ADAMTS13)
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase I
Standard IndicationThrombocytopenia
Indication DetailsTreat hereditary thrombotic thrombocytopenic purpura (TTP); Treat thrombotic thrombocytopenic purpura (TTP)
Regulatory Designation U.S. - Orphan Drug (Treat hereditary thrombotic thrombocytopenic purpura (TTP))

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today